Joanne M. Munck

Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K

Joanne M. Munck, Michael A. Batey, Yan Zhao et al. · Molecular Cancer Therapeutics · 2012 · 131 citations · Full text

Medicine, Oncology, Pharmacology +11

The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer

Fang Fang, Joanne M. Munck, Jessica Tang et al. · Clinical Cancer Research · 2014 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of HSP90 by AT13387 Delays the Emergence of Resistance to BRAF Inhibitors and Overcomes Resistance to Dual BRAF and MEK Inhibition in Melanoma Models

Tomoko Smyth, Kim H.T. Paraiso, Keisha Hearn et al. · Molecular Cancer Therapeutics · 2014 · 91 citations · Full text

Medicine, Oncology, Pharmacology +15

DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival

Liam Cornell, Joanne M. Munck, Clara Alsinet et al. · Clinical Cancer Research · 2014 · 88 citations · Full text

Medicine, Cancer Biology, Oncology +17

ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

George A. Ward, Edward J. Lewis, Jong Sook Ahn et al. · Molecular Cancer Therapeutics · 2018 · 74 citations

Medicine, Oncology, Pharmacology +17